DK175282B1 - Anvendelse af 4-[1-(2,3-dimetylfenyl)-ætyl]-1H-imidazol til fremstilling af lægemidler til perioperativ anvendelse - Google Patents

Anvendelse af 4-[1-(2,3-dimetylfenyl)-ætyl]-1H-imidazol til fremstilling af lægemidler til perioperativ anvendelse Download PDF

Info

Publication number
DK175282B1
DK175282B1 DK198900464A DK46489A DK175282B1 DK 175282 B1 DK175282 B1 DK 175282B1 DK 198900464 A DK198900464 A DK 198900464A DK 46489 A DK46489 A DK 46489A DK 175282 B1 DK175282 B1 DK 175282B1
Authority
DK
Denmark
Prior art keywords
imidazole
dimethylphenyl
ethyl
manufacture
pharmaceutically acceptable
Prior art date
Application number
DK198900464A
Other languages
Danish (da)
English (en)
Other versions
DK46489D0 (da
DK46489A (da
Inventor
Mervyn Maze
Mika Scheinin
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of DK46489D0 publication Critical patent/DK46489D0/da
Publication of DK46489A publication Critical patent/DK46489A/da
Application granted granted Critical
Publication of DK175282B1 publication Critical patent/DK175282B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198900464A 1988-02-29 1989-02-02 Anvendelse af 4-[1-(2,3-dimetylfenyl)-ætyl]-1H-imidazol til fremstilling af lægemidler til perioperativ anvendelse DK175282B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8804683 1988-02-29
GB8804683A GB2215206B (en) 1988-02-29 1988-02-29 4-substituted imidazole derivatives useful in perioperative care

Publications (3)

Publication Number Publication Date
DK46489D0 DK46489D0 (da) 1989-02-02
DK46489A DK46489A (da) 1989-08-30
DK175282B1 true DK175282B1 (da) 2004-08-09

Family

ID=10632543

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198900464A DK175282B1 (da) 1988-02-29 1989-02-02 Anvendelse af 4-[1-(2,3-dimetylfenyl)-ætyl]-1H-imidazol til fremstilling af lægemidler til perioperativ anvendelse

Country Status (13)

Country Link
EP (1) EP0331374B1 (de)
JP (1) JP2856410B2 (de)
KR (1) KR0136790B1 (de)
AT (1) ATE101514T1 (de)
AU (1) AU611262B2 (de)
CA (1) CA1338556C (de)
DE (1) DE68913054T2 (de)
DK (1) DK175282B1 (de)
GB (1) GB2215206B (de)
HU (1) HU202751B (de)
IE (1) IE60538B1 (de)
NZ (1) NZ228125A (de)
ZA (1) ZA891493B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB9111732D0 (en) * 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
GB2281206A (en) * 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine
US6028068A (en) * 1995-12-28 2000-02-22 The Procter & Gamble Company Substituted 6H-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
WO1997024352A1 (fr) * 1995-12-28 1997-07-10 The Procter & Gamble Company 6-h-1,3,4-thiadiazine-2-amines substitues, leur utilisation en qualite d'agents anesthesiques, cardio-vasculaires et hypometaboliques, et composition pharmaceutique les contenant
ATE207918T1 (de) * 1995-12-28 2001-11-15 Procter & Gamble Substituierte 6-r-1,3,4-thiadiazin-2-amine, deren verwendung als anaesthetische, cardiovaskulare und hypometabolische mittel, und eine sie enthaltende pharmazeutische zubereitung
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
EP1981880B1 (de) * 2006-01-27 2010-02-24 F.Hoffmann-La Roche Ag Verwendung von 4-imidazol-derivaten für zns-erkrankungen
AU2007312390B2 (en) 2006-10-19 2013-03-28 F. Hoffmann-La Roche Ag Aminomethyl-4-imidazoles
JP5064511B2 (ja) 2006-11-02 2012-10-31 エフ．ホフマン−ラ ロシュ アーゲー 痕跡アミン関連受容体調節剤としての置換２−イミダゾール
RU2456281C2 (ru) 2006-11-16 2012-07-20 Ф. Хоффманн-Ля Рош Аг Замещенные 4-имидазолы, способ их получения и их применение
ATE509628T1 (de) 2006-12-13 2011-06-15 Hoffmann La Roche Neue 2-imidazole als liganden für trace amine associated receptors (taar)
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
BRPI0806940A2 (pt) 2007-02-02 2014-05-06 Hoffmann La Roche 2-amino-oxazolinas como ligantes taar1 para distúrbios do snc
MX2009008465A (es) 2007-02-15 2009-08-20 Hoffmann La Roche Nuevas 2-aminooxazolinas como ligandos de taar1.
AU2008270445A1 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (TAARs)
MX2009013745A (es) 2007-07-03 2010-01-26 Hoffmann La Roche 4-imidazolinas y su uso como antidepresivos.
CN101765587A (zh) 2007-07-27 2010-06-30 弗·哈夫曼-拉罗切有限公司 作为taar配体的2-氮杂环丁烷甲胺类和2-吡咯烷甲胺类
CA2695331A1 (en) 2007-08-03 2009-02-12 F. Hoffmann-La Roche Ag Pyridinecarboxamide and benzamide derivatives as taar1 ligands
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
EP2395999B1 (de) 2009-02-13 2017-09-13 Allergan, Inc. Pharmazeutische zusammensetzungen mit (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
US9095576B2 (en) 2011-11-21 2015-08-04 Allergan, Inc. Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
RU2648449C2 (ru) 2013-10-07 2018-03-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина
TWI629066B (zh) 2013-10-07 2018-07-11 帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
RU2018105761A (ru) 2013-10-07 2019-02-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Устройства для трансдермальной доставки дексмедетомидина и способы их применения
BR112018015389B1 (pt) 2016-03-17 2023-12-19 F. Hoffmann-La Roche Ag Derivado de 5-etil-4-metil-pirazol-3-carboxamida, seu processo de fabricação, preparação farmacêutica oral e uso
CA3038354C (en) * 2016-10-31 2021-08-17 Teikoku Pharma Usa, Inc. Methods of managing pain using dexmedetomidine transdermal delivery devices

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3190802A (en) 1961-10-09 1965-06-22 Boehringer Sohn Ingelheim Shaving composition and method of using same
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative

Also Published As

Publication number Publication date
EP0331374B1 (de) 1994-02-16
HUT51139A (en) 1990-04-28
CA1338556C (en) 1996-08-27
DK46489D0 (da) 1989-02-02
EP0331374A2 (de) 1989-09-06
JPH01294623A (ja) 1989-11-28
KR890012647A (ko) 1989-09-18
GB2215206A (en) 1989-09-20
IE60538B1 (en) 1994-07-27
HU202751B (en) 1991-04-29
DE68913054T2 (de) 1994-07-07
DE68913054D1 (de) 1994-03-24
JP2856410B2 (ja) 1999-02-10
AU3027289A (en) 1989-08-31
AU611262B2 (en) 1991-06-06
ZA891493B (en) 1989-11-29
ATE101514T1 (de) 1994-03-15
DK46489A (da) 1989-08-30
GB8804683D0 (en) 1988-03-30
EP0331374A3 (en) 1990-10-10
GB2215206B (en) 1991-07-03
KR0136790B1 (ko) 1998-04-25
NZ228125A (en) 1996-12-20
IE890639L (en) 1989-08-29

Similar Documents

Publication Publication Date Title
DK175282B1 (da) Anvendelse af 4-[1-(2,3-dimetylfenyl)-ætyl]-1H-imidazol til fremstilling af lægemidler til perioperativ anvendelse
Karhuvaara et al. Rapid reversal of alpha 2‐adrenoceptor agonist effects by atipamezole in human volunteers.
Marcilla et al. Cardiopulmonary effects of two constant rate infusions of dexmedetomidine in isoflurane anaesthetized ponies
Toivonen et al. Clonidine premedication: a useful adjunct in producing deliberate hypotension
Di Bella et al. Respiratory and hemodynamic effects of 2 protocols of low-dose infusion of dexmedetomidine in dogs under isoflurane anesthesia
US5344840A (en) 4-substituted imidazole derivatives useful in perioperative care
AU2003229724B2 (en) Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
Kutter et al. Cardiopulmonary effects of dexmedetomidine in goats and sheep anaesthetised with sevoflurane
Elmfeldt et al. Antihypertensive effects of felodipine compared with placebo
Jaakola et al. Intramuscular dexmedetomidine premedication—an alternative to midazolam‐fentanyl‐combination in elective hysterectomy?
Doak et al. Oral clonidine premedication attenuates the haemodynamic effects associated with ketamine anaesthetic induction in humans
US4259342A (en) Antianginal treatment with azepine derivatives
Olufolabi et al. A randomized, prospective double-blind comparison of the efficacy of generic propofol (sulphite additive) with Diprivan®
Ise et al. Clonidine as a drug for intravenous conscious sedation
Wicaksono et al. Clonidine premedication was better in preventing hemodynamic response changes post laryngoscopy and endotracheal intubation compared to fentanyl premedication
JPS60202819A (ja) 高血圧および血栓塞栓性疾患治療用の医薬生成物
Hentry et al. Comparative Efficacy of Oral Metaprolol Vs Oral Clonidine as Premedicants for Hypotensive Anesthesia for Patients Undergoingfunctional Endoscopic Sinus Surgery under General Anesthesia
Maqbool et al. Comparative Clinical Evaluation of Preoperative Oral Pregabalin and Melatonin for Attenuation of Haemodynamic Responses to Laryngoscopy and Intubation.
Arisandi The Effect of Sevoflurane and Isofluran Inhalation Anesthesia on Hemodynamic Changes in Operational Patients at Rsup Dr. M. Djamil Padang
Lokesh et al. Dose sparing of induction dose of propofol by fentanyl and butorphanol: A comparison based on entropy analysis
JP4741131B2 (ja) 低血圧およびショックの治療または予防
Carabine et al. The effect of intravenous clonidine on the forearm circulation
JP4784037B2 (ja) 塩酸ランジオロールを含有する頻脈性不整脈の治療剤
Kaya et al. The Effects Of Intramuscular Dexmedetomidine Premedication On Hemodynamics, Plasma Norepinephrine, Cortisol And Glucose Consentrations
Rani et al. Evaluation of Oral Clonidine as a Premedicant in Attenuating Hemodynamic Stress Response to Laryngoscopy and Intubation ‑A Clinical Study

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK